BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23762379)

  • 21. The Adenosinergic System in Diabetic Retinopathy.
    Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
    J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imbalance of the Nerve Growth Factor and Its Precursor: Implication in Diabetic Retinopathy.
    Mohamed R; El-Remessy AB
    J Clin Exp Ophthalmol; 2015 Oct; 6(5):. PubMed ID: 26807305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular Signature of SIL1 Depletion: Disease Pathogenesis due to Alterations in Protein Composition Beyond the ER Machinery.
    Roos A; Kollipara L; Buchkremer S; Labisch T; Brauers E; Gatz C; Lentz C; Gerardo-Nava J; Weis J; Zahedi RP
    Mol Neurobiol; 2016 Oct; 53(8):5527-41. PubMed ID: 26468156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EPO protects Müller cell under high glucose state through BDNF/TrkB pathway.
    Wang P; Xia F
    Int J Clin Exp Pathol; 2015; 8(7):8083-90. PubMed ID: 26339375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotrophic Effects of Mu Bie Zi (Momordica cochinchinensis) Seed Elucidated by High-Throughput Screening of Natural Products for NGF Mimetic Effects in PC-12 Cells.
    Mazzio E; Georges B; McTier O; Soliman KF
    Neurochem Res; 2015 Oct; 40(10):2102-12. PubMed ID: 25862192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary retinal cultures as a tool for modeling diabetic retinopathy: an overview.
    Matteucci A; Varano M; Mallozzi C; Gaddini L; Villa M; Gabrielli S; Formisano G; Pricci F; Malchiodi-Albedi F
    Biomed Res Int; 2015; 2015():364924. PubMed ID: 25688355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Mohammad G; Siddiquei MM; Alam K; Mousa A; Opdenakker G
    Lipids Health Dis; 2014 Dec; 13():187. PubMed ID: 25496321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve growth factor in diabetic retinopathy: beyond neurons.
    Mysona BA; Shanab AY; Elshaer SL; El-Remessy AB
    Expert Rev Ophthalmol; 2014 Apr; 9(2):99-107. PubMed ID: 25031607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional properties of the TRK family of neurotrophin receptors.
    Barbacid M
    Ann N Y Acad Sci; 1995 Sep; 766():442-58. PubMed ID: 7486690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretogranin III: a diabetic retinopathy-selective angiogenic factor.
    Li W; Webster KA; LeBlanc ME; Tian H
    Cell Mol Life Sci; 2018 Feb; 75(4):635-647. PubMed ID: 28856381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotrophins and neurotrophin receptors in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; De Hertogh G; Nawaz MI; Van Den Eynde K; Siddiquei MM; Struyf S; Opdenakker G; Geboes K
    PLoS One; 2013; 8(6):e65472. PubMed ID: 23762379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
    Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.
    Boss JD; Singh PK; Pandya HK; Tosi J; Kim C; Tewari A; Juzych MS; Abrams GW; Kumar A
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5594-5603. PubMed ID: 29084332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.